BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31322539)

  • 1. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
    Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
    Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
    Zhao N; Guo Y; He Y; Chen Y; Xing J
    J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of eukaryotic translation initiation factor 3B and its correlation with tumor characteristics as well as prognosis in non-small cell lung cancer patients: a retrospective study.
    Liu C; Li X; Tian J; Zhang S; Liu Y; Zhai X; Feng Q
    J BUON; 2020; 25(5):2350-2357. PubMed ID: 33277855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
    Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
    Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer.
    Liang S; Zhou Y; Chen Y; Ke G; Wen H; Wu X
    Int J Gynecol Cancer; 2014 Jun; 24(5):908-15. PubMed ID: 24844222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
    Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
    Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
    BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
    Sasano T; Mabuchi S; Kuroda H; Takahashi R; Kozasa K; Isohashi F; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2016 Mar; 26(3):528-33. PubMed ID: 26825839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of perivascular lymphocytic infiltrates on survival of patients with invasive cervical cancer.
    Yamazawa K; Matsui H; Ishikura H; Seki K; Mitsuhashi A; Sekiya S
    J Immunother; 2003; 26(2):149-55. PubMed ID: 12616106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P27 as a prognostic factor of early cervical carcinoma.
    Bouda J; Hes O; Koprivova M; Pesek M; Svoboda T; Boudova L
    Int J Gynecol Cancer; 2013 Jan; 23(1):164-9. PubMed ID: 23221604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of α5β1-integrin expression in cervical cancer.
    Wang HY; Chen Z; Wang ZH; Wang H; Huang LM
    Asian Pac J Cancer Prev; 2013; 14(6):3891-5. PubMed ID: 23886203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing simultaneous positive expression of EZH2 and P53 protein to improve predictive value in cervical squamous cell carcinoma.
    Chen SQ; Zhang HM; Li JB; Jiang HY; Fan L; Kong LZ; Yao SZ
    Int J Gynecol Cancer; 2014 Nov; 24(9):1653-8. PubMed ID: 25275664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.